VL52, Inc. is pioneering an approach to hack cross-kingdom communication for the development of a novel delivery platform for sustainable precision targeting and therapeutic intervention. This platform technology is based on strong foundational IP developed within the Flagship Pioneering innovation foundry. VL52 follows in the footsteps of VentureLabs companies such as Moderna Therapeutics, Seres Therapeutics, Rubius Therapeutics, Indigo Agriculture and Inari Agriculture.
- Ignacio Martinez
- Ellen van Rooijen, PhD